Carbohydrate engineered cells for regenerative medicine

Advanced Drug Delivery Reviews

Volumn 62, Issue 7-8, 2010, Pages 671-682

  Du, Jian ^a   Yarema, Kevin J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Glucosamine; Glycan and oligosaccharide engineering; Hexosamine based drugs; ManNAc analogs; Metabolic glycoengineering; Sialic acid; Tissue engineering

Indexed keywords

GLUCOSAMINE; GLUCOSAMINES; GLYCAN AND OLIGOSACCHARIDE ENGINEERING; MANNAC ANALOGS; SIALIC ACIDS;

ACIDS; CARBOHYDRATES; CARBOXYLIC ACIDS; ENGINEERING; GLUCOSE; METABOLISM; OLIGOSACCHARIDES; STEM CELLS; SUGAR (SUCROSE); TISSUE;

TISSUE ENGINEERING;

CARBOHYDRATE; FIBROBLAST GROWTH FACTOR 2; GLUCOSAMINE; GLYCOSAMINOGLYCAN; NOTCH RECEPTOR; SIALIC ACID;

CARBOHYDRATE METABOLISM; CARTILAGE DEGENERATION; CELL ADHESION; CELL FATE; CELL SURFACE; EXTRACELLULAR MATRIX; GLYCOSYLATION; IMMUNOGENICITY; METABOLIC ENGINEERING; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVE REGENERATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; TISSUE ENGINEERING;

ANIMALS; CARBOHYDRATE METABOLISM; EXTRACELLULAR MATRIX; GLYCOCALYX; GLYCOSAMINOGLYCANS; HUMANS; OLIGOSACCHARIDES; PROTEOGLYCANS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 77953687296     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2010.01.003     Document Type: Review

References (140)

1. Spradling A., Drummond-Barbosa D., Kai T. Stem cells find their niche. Nature 2001, 414:98-104.
2. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 2005, 23:47-55.
3. Esko J.D., Kimata K., Lindahl U. Chapter 16: Proteoglycans and Sulfated Glycosaminoglycans. Essentials of Glycobiology 2009, Cold Spring Harbor Press, Woodbury, New York. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler (Eds.).
4. Hodde J.P., Badylak S.F., Brightman A.O., Voytik-Harbin S.L. Glycosaminoglycan content of small intestinal submucosa. Tiss. Eng. 1996, 2:209-217.
5. Martin G.R., Timpl R., Kuhn K. Basement-membrane proteins - molecular structure and function. Ad. Prot. Chem. 1988, 39:1-50.
6. Bernfield M., Kokenyesi R., Kato M., Hinkes M.T., Spring J., Gallo R.L., Lose E.J. Biology of the syndecans - a family of transmembrane heparan-sulfate proteoglycans. Annu. Rev. Cell. Biol. 1992, 8:365-393.
7. Cohen M., Joester D., Geiger B., Addadi L. Spatial and temporal sequence of events in cell adhesion: from molecular recognition to focal adhesion assembly. Chem. Bio. Chem. 2004, 5:1393-1399.
8. Werz D.B., Ranzinger R., Herget S., Adibekian A., von der Lieth C.-W., Seeberger P.H. Exploring the structural diversity of mammalian carbohydrates ("glycospace") by statistical databank analysis. ACS Chem. Biol. 2007, 2:685-691.
9. Spiro R.G. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 2002, 12:43R-56R.
10. Chester M.A. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) Nomenclature of glycolipids: Recommendations 1997. Glycoconjug. J. 1999, 16:1-6.
11. Chen H., Wang Z., Sun Z., Kim E.J., Yarema K.J. Mammalian, Glycosylation: An Overview of Carbohydrate Biosynthesis. Handbook of Carbohydrate Engineering 2005, 1-48. Francis & Taylor/CRC Press, Boca Raton, FL. K.J. Yarema (Ed.).
12. Gabius H.-J., Siebert H.-C., André S., Jiménez-Barbero J., Rüdiger H. Chemical biology of the sugar code. Chem. Bio. Chem. 2004, 5:740-764.
13. Solis D., Jimenez-Barbero J., Kaltner H., Romero A., Siebert H.C., von der Lieth C.W., Gabius H.J. Towards defining the role of glycans as hardware in information storage and transfer: basic principles, experimental approaches and recent progress. Cells Tissues Organs 2001, 168:5-23.
14. Dam T.K., Brewer C.F. Thermodynamic studies of lectin-carbohydrate interactions by isothermal titration calorimetry. Chem. Rev. 2002, 102:387-429.
15. Gabius H.J. Biological information transfer beyond the genetic code: the sugar code. Naturwissenschaften 2000, 87:108-121.
16. Gabius H.J. Glycans: bioactive signals decoded by lectins. Biochem. Soc. Trans. 2008, 36:1491-1496.
17. Rao R.R., Johnson A.V., Stice S.L. Cell Surface Markers in Human Embryonic Stem Cells. Stem Cell Assays: Methods in Molecular Biology 2007, 51-61. New York, Humana Press, New York. M.C. Vemuri (Ed.).
18. Lanctot P.M., Gage F.H., Varki A.P. The glycans of stem cells. Curr. Opin. Chem. Biol. 2007, 11:373-380.
19. Zheng T., Peelen D., Smith L.M. Lectin arrays for profiling cell surface carbohydrate expression. J. Am. Chem. Soc. 2005, 127:9982-9983.
20. Hsu K.-L., Mahal L.K. Sweet tasting chips: microarray-based analysis of glycans. Curr. Opin. Chem. Biol. 2009, 13:427-432.
21. Campbell C.T., Yarema K.J. Large-scale approaches for glycobiology. Gen. Biol 2005, 6. Article 236.
22. Mueller T., Eildermann K., Dhir R., Schlatt S., Behr R. Glycan stem-cell markers are specifically expressed by spermatogonia in the adult non-human primate testis. Hum. Reprod. 2008, 23:2292-2298.
23. Kiessling L.L., Pohl S. Strength in numbers: non-natural polyvalent carbohydrate derivatives. Chem. Biol. 1996, 3:71-77.
24. Lundquist J.J., Toone E.J. The cluster glycoside effect. Chem. Rev. 2002, 102:555-578.
25. Aich U., Yarema K.J. Glycobiology and Immunology 2009, 1-54. John Wiley & Sons, Hoboken, New Jersey. Z. Guo, G.-J. Boons (Eds.).
26. Cummings R.D., Etzler M.E. Chapter 45: Antibodies and Lectins in Glycan Analysis. Essentials of Glycobiology 2009, Cold Spring Harbor Press, Woodbury, New York. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler (Eds.).
27. Muramatsu T., Muramatsu H. Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconjug. J. 2004, 21:41-45.
28. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
29. Helenius A., Aebi M. Intracellular functions of N-linked glycans. Science 2001, 291:2364-2369.
30. Krause D.S., Ito T., Fackler M.J., Smith O.M., Collector M.I., Sharkis S.J., May W.S. Characterization of murine Cd34, a marker for hematopoietic progenitor and stem cells. Blood 1994, 84:691-701.
31. Krause D.S., Fackler M.J., Civin C.I., May W.S. CD34: structure, biology, and clinical utility. Blood 1996, 87:1-13.
32. Lanza F., Healy L., Sutherland D.R. Structural and functional features of the CD34 antigen: an update. J. Biol. Regul. Homeost. Agents 2001, 15:1-13.
33. Zulli A., Buxton B.F., Merrilees M., Hare D.L. Human diseased arteries contain cells expressing leukocytic and embryonic stem cell markers. Hum. Pathol. 2008, 39:657-665.
34. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
35. Thomson J.A., Kalishman J., Golos T.G., Durning M., Harris C.P., Becker R.A., Hearn J.P. Isolation of a primate embryonic stem-cell line. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7844-7848.
36. Sasaki E., Hanazawa K., Kurita R., Akatsuka A., Yoshizaki T., Ishii H., Tanioka Y., Ohnishi Y., Suemizu H., Sugawara A., Tamaoki N., Izawa K., Nakazaki Y., Haniada H., Suemori H., Asano S., Nakatsuji N., Okano H., Tani K. Establishment of novel embryonic stem cell lines derived from the common marmoset (Callithrix jacchus). Stem Cells 2005, 23:1304-1313.
37. Thomson J.A., Kalishman J., Golos T.G., Durning M., Harris C.P., Hearn J.P. Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol. Reprod. 1996, 55:254-259.
38. Shamblott M.J., Axelman J., Wang S.P., Bugg E.M., Littlefield J.W., Donovan P.J., Blumenthal P.D., Huggins G.R., Gearhart J.D. Derivation of pluripotent stem cells horn cultured human primordial germ cells. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13726-13731.
39. Reubinoff B.E., Pera M.F., Fong C.-Y., Trounson A., Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 2000, 18:399-404.
40. Carpenter M.K., Rosler E., Rao M.S. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 2003, 5:79-88.
41. Badcock G., Pigott C., Goepel J., Andrews P.W. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res. 1999, 59:4715-4719.
42. Kannagi R., Cochran N.A., Ishigami F., Hakomori S., Andrews P.W., Knowles B.B., Solter D. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EBMO J. 1983, 2:2355-2361.
43. Park T.S., Han J.Y. Derivation and characterization of pluripotent embryonic germ cells in chicken. Mol. Reprod. Dev. 2000, 56:475-482.
44. Kuhholzer B., Baguisi A., Overstrom E.W. Long-term culture and characterization of goat primordial germ cells. Theriogenology 2000, 53:1071-1079.
45. D'Costa S., Petitte J.N. Characterization of stage-specific embryonic antigen-1 (SSEA-1) expression during early development of the turkey embryo. Int. J. Dev. Biol. 1999, 43:349-356.
46. Zhang Y., Liu S., Liu Y., Wang Z., Wang X., Yan Q. Overexpression of fucosyltransferase VII (FUT7) promotes embryo adhesion and implantation. Fertil. Steril. 2009, 91:908-914.
47. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3:97-130.
48. Lowe J.B. Glycosylation in the control of selectin counter-receptor structure and function. Immunol. Rev. 2002, 186:19-36.
49. Handel T.M., Johnson Z., Crown S.E., Lau E.K., Sweeney M., Proudfoot A.E. Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu. Rev. Biochem. 2005, 74:385-410.
50. Paulson J.C., Blixt O., Collins B.E. Sweet spots in functional glycomics. Nat. Chem. Biol. 2006, 2:238-248.
51. Ohtsubo K., Marth J.D. Glycosylation in cellular mechanisms of health and disease. Cell 2006, 126:855-867.
52. Zhang L., Zhang Y., Ten Hagen K.G. A mucin-type O-glycosyltransferase modulates cell adhesion during Drosophila development. J. Biol. Chem. 2008, 283:34076-34086.
53. Zachara N.E., Hart G.W. Cell signaling, the essential role of O-GlcNAc!. Biochim. Biophys. Acta 2006, 1761:599-617.
54. Hebert D.N., Garman S.C., Molinari M. The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags. Trends Cell Biol. 2005, 15:364-370.
55. Jones D.L., Wagers A.J. No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell Biol. 2008, 9:11-21.
56. Lie D.-C., Colamarino S.A., Song H.-J., Désiré L., Mira H., Consiglio A., Lein E.S., Jessberger S., Lansford H., Dearie A.R., Gage F.H. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005, 437:1370-1375.
57. Bullock S.L., Fletcher J.M., Beddington R.S.P., Wilson V.A. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 1998, 12:1894-1906.
58. Sampathkumar S.-G., Li A.V., Jones M.B., Sun Z., Yarema K.J. Metabolic installation of thiols into sialic acid modulates adhesion and stem cell biology. Nat. Chem. Biol. 2006, 2:149-152.
59. Kobayashi T., Habuchi H., Tamura K., Ide H., Kimata K. Essential role of heparan sulfate 2-O-sulfotransferase in chick limb bud patterning and development. J. Biol. Chem. 2007, 282:19589-19597.
60. Raman R., Sasisekharan R. Cooperativity in glycan-protein interactions. Chem. Biol. 2007, 14:873-874.
61. Gama C.I., Tully S.E., Sotogaku N., Clark P.M., Rawat M., Vaidehi N., Goddard W.A., Nishi A., Hsieh-Wilson L.C. Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat. Chem. Biol. 2006, 2:467-473.
62. Haines N., Irvine K.D. Glycosylation regulates notch signalling. Nat. Rev. Mol. Cell Biol. 2003, 4:786-797.
63. Moloney D.J., Shair L.H., Lu F.M., Xia J., Locke R., Matta K.L., Haltiwanger R.S. Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules. J. Biol. Chem. 2000, 275:9604-9611.
64. Moloney D.J., Panin V.M., Johnston S.H., Chen J.H., Shao L., Wilson R., Wang Y., Stanley P., Irvine K.D., Haltiwanger R.S., Vogt T.F. Fringe is a glycosyltransferase that modifies Notch. Nature 2000, 406:369-375.
65. Krambeck F.J., Bennun S.V., Narang S., Choi S.S., Yarema K.J., Betenbaugh M.J. A mathematical model to derive N-glycan structures and cellular enzyme activities from mass spectrometric data. Glycobiology 2009, 19:1163-1175.
66. Satomaa T., Heiskanen A., Mikkola M., Olsson C., Blomqvist M., Tiittanen M., Jaatinen T., Aitio O., Olonen A., Helin J., Hiltunen J., Natunen J., Tuuri T., Otonkoski T., Saarinen J., Laine J. The N-glycome of human embryonic stem cells. BMC Cell Biol. 2009, 10:42.
67. Kayser H., Zeitler R., Kannicht C., Grunow D., Nuck R., Reutter W. Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors. J. Biol. Chem. 1992, 267:16934-16938.
68. Kayser H., Geilen C.C., Paul C., Zeitler R., Reutter W. New amino sugar analogues are incorporated at different rates into glycoproteins of mouse organs. Experientia 1993, 49:885-887.
69. Sampathkumar S.-G., Jones M.B., Yarema K.J. Metabolic expression of thiol-derivatized sialic acids on the cell surface and their quantitative estimation by flow cytometry. Nat. Protoc. 2006, 1:1840-1851.
70. Mahal L.K., Yarema K.J., Bertozzi C.R. Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. Science 1997, 276:1125-1128.
71. Saxon E., Bertozzi C.R. Cell surface engineering by a modified Staudinger reaction. Science 2000, 287:2007-2010.
72. Du J., Meledeo M.A., Wang Z., Khanna H.S., Paruchuri V.D., Yarema K.J. Metabolic glycoengineering: sialic acid and beyond. Glycobiology 2009, 19:1382-1401.
73. Keppler O.T., Horstkorte R., Pawlita M., Schmidt C., Reutter W. Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology 2001, 11:11R-18R.
74. Hinderlich S., Oetke C., Pawlita M. Biochemical Engineering of Sialic Acids. Handbook of Carbohydrate Engineering 2005, 387-405. Francis & Taylor/CRC Press, Boca Raton, FL. K.J. Yarema (Ed.).
75. Campbell C.T., Sampathkumar S.-G., Weier C., Yarema K.J. Metabolic oligosaccharide engineering: perspectives, applications, and future directions. Mol. Biosyst. 2007, 3:187-194.
76. Aich U., Yarema K.J. Metabolic Oligosaccharide Engineering: Perspectives, Applications, and Future Directions. Glycosciences 2008, 2136-2190. Springer-Verlag, Berlin Heidelberg. 2 ed. B. Fraser-Reid, K. Tatsuta, J. Thiem (Eds.).
77. Schmidt C., Stehling P., Schnitzer J., Reutter W., Horstkorte R. Biochemical engineering of neural cell surfaces by the synthetic N-propanoyl-substituted neuraminic acid precursor. J. Biol. Chem. 1998, 273:19146-19152.
78. Sampathkumar S.-G., Li A., Yarema K.J. Sialic acid and the central nervous system: perspectives on biological functions, detection, imaging methods and manipulation. CNS Neurol. Disorders Drug Targets 2006, 5:425-440.
79. Büttner B., Kannicht C., Schmidt C., Löster K., Reutter W., Lee H.-Y., Nöhring S., Horstkorte R. Biochemical engineering of cell surface sialic acids stimulates axonal growth. J. Neurosci. 2002, 22:8869-8875.
80. Collins B.E., Fralich T.J., Itonori S., Ichikawa Y., Schnaar R.L. Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells. Glycobiology 2000, 10:11-20.
81. Villavicencio-Lorini P., Laabs S., Danker K., Reutter W., Horstkorte R. Biochemical engineering of the acyl side chain of sialic acids stimulates integrin-dependent adhesion of HL60 cells to fibronectin. J. Mol. Med. 2002, 80:671-677.
82. Derfoul A., Miyoshi A.D., Freeman D.E., Tuan R.S. Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthr. Cartil. 2007, 15:646-655.
83. Setnikar I., Giachetti C., Zanolo G. Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [C-14] glucosamine to the rat. Pharmatherapeutica 1984, 3:538-550.
84. Matheson A.J., Perry C.M. Glucosamine - a review of its use in the management of osteoarthritis. Drugs Aging 2003, 20:1041-1060.
85. Richy F., Bruyere O., Ethgen O., Cucherat M., Henrotin Y., Reginster J.Y. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis - a comprehensive meta-analysis. Arch. Intern. Med. 2003, 163:1514-1522.
86. Bruyere O., Pavelka K., Rovati L.C., Deroisy R., Olejarova M., Gatterova J., Giacovelli G., Reginster J.Y. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause 2004, 11:138-143.
87. McAlindon T.E., LaValley M.P., Gulin J.P., Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis - a systematic quality assessment and meta-analysis. J. Am. Med. Assoc. 2000, 283:1469-1475.
88. Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., Giacovelli G., Henrotin Y., Dacre J.E., Gossett C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001, 357:251-256.
89. Varghese S., Theprungsirikul P., Sahani S., Hwang N., Yarema K.J., Elisseeff J.H. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Osteoarthr. Cartil. 2007, 15:59-68.
90. Silbert J.E. Dietary glucosamine under question. Glycobiology 2009, 19:564-567.
91. Dodge G.R., Jimenez S.A. Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthr. Cartil. 2003, 11:424-432.
92. Chan P.S., Caron J.P., Rosa G.J.M., Orth M.W. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E-2 in articular cartilage explants. Osteoarthr. Cartil. 2005, 13:387-394.
93. Hwang N.S., Varghese S., Theprungsirikul P., Canver A., Elisseeff J. Enhanced chondrogenic differentiation of murine embryonic stem cells in hydrogels with glucosamine. Biomaterials 2006, 27:6015-6023.
94. Poustie M.W., Carran J., McElerney K., Dixon S.J., Anastassiades T.P., Bernier S.M. N-Butyryl glucosamine increases matrix gene expression by chondrocytes. J. Pharmacol. Exp. Ther. 2004, 311:610-616.
95. Sampathkumar S.-G., Campbell C.T., Weier C., Yarema K.J. Short-chain fatty acid-hexosamine cancer prodrugs: the sugar matters!. Drug. Future. 2006, 31:1099-1116.
96. Kontou M., Bauer C., Reutter W., Horstkorte R. Sialic acid metabolism is involved in the regulation of gene expression during neuronal differentiation of PC12 cells. Glycoconjug. J. 2008, 25:237-244.
97. Kontou M., Weidemann W., Bork K., Horstkorte R. Beyond glycosylation: sialic acid precursors act as signaling molecules and are involved in cellular control of differentiation of PC12 cells. Biol. Chem. 2009, 390:575-579.
98. Friedman S.J., Skehan P. Membrane-active drugs potentiate the killing of tumor cells by D-glucosamine. Proc. Natl. Acad. Sci. U.S.A. 1980, 77:1172-1176.
99. Zanghi J.A., Mendoza T.P., Schmelzer A.E., Knop R.H., Miller W.M. Role of nucleotide sugar pools in the inhibition of NCAM polysialylation by ammonia. Biotechnol. Prog. 1998, 14:834-844.
100. Zanghi J.A., Mendoza T.P., Knop R.H., Miller W.M. Ammonia decreases NCAM polysialylation in Chinese hamster ovary and small cell lung cancer cells. J. Cell. Physiol. 1998, 177:248-263.
101. Lau K.S., Dennis J.W. N-Glycans in cancer progression. Glycobiology 2008, 18:750-760.
102. McClain D.A., Paterson A.J., Roos M.D., Wei X., Kudlow J.E. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:8150-8154.
103. Lau K.S., Partridge E.A., Grigorian A., Silvescu C.I., Reinhold V.N., Demetriou M., Dennis J.W. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 2007, 129:123-134.
104. Wang Z., Sun Z., Li A.V., Yarema K.J. Roles for GNE outside of sialic acid biosynthesis: modulation of sialyltransferase and BiP expression, GM3 and GD3 biosynthesis, proliferation and apoptosis, and ERK1/2 phosphorylation. J. Biol. Chem. 2006, 281:27016-27028.
105. Sampathkumar S.-G., Li A.V., Yarema K.J. Synthesis of non-natural ManNAc analogs for the expression of thiols on cell surface sialic acids. Nat. Protoc. 2006, 1:2377-2385.
106. Sampathkumar S.-G., Jones M.B., Meledeo M.A., Campbell C.T., Choi S.S., Hida K., Gomutputra P., Sheh A., Gilmartin T., Head S.R., Yarema K.J. Targeting glycosylation pathways and the cell cycle: sugar- dependent activity of butyrate-carbohydrate cancer prodrugs. Chem. Biol. 2006, 13:1265-1275.
107. Hakomori S.-I. The glycosynapse. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:225-232.
108. Allende M.L., Proia R.L. Lubricating cell signaling pathways with gangliosides. Curr. Opin. Struct. Biol. 2002, 12:587-592.
109. Brinkman-Van der Linden E.C., Sjoberg E.R., Juneja L.R., Crocker P.R., Varki N., Varki A. Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs. J. Biol. Chem. 2000, 275:8633-8640.
110. Higa H.H., Rogers G.N., Paulson J.C. Influenza virus hemagglutinins differentiate between receptor determinants bearing N-acetyl-, N-glycolyl-, and N, O-diacetylneuraminic acids. Virology 1985, 144:279-282.
111. Varki A. Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution. Am. J. Phys. Anthropol. 2002, 116:54-69.
112. Discher D.E., Mooney D.J., Zandstra P.W. Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324:1673-1677.
113. Iwasaki H., Suda T. Cancer stem cells and their niche. Cancer Sci. 2009, 100:1166-1172.
114. De Bank P.A., Kellam B., Kendall D.A., Shakesheff K.M. Surface engineering of living myoblasts via selective periodate oxidation. Biotechnol. Bioeng. 2003, 81:800-808.
115. Iwasaki Y., Maie H., Akiyoshi K. Cell-specific delivery of polymeric nanoparticles to carbohydrate-tagging cells. Biomacromolecules 2007, 8:3162-3168.
116. Iwasaki Y., Tabata E., Kurita K., Akiyoshi K. Selective cell attachment to a biomimetic polymer surface through the recognition of cell-surface tags. Bioconjug. Chem. 2005, 16:567-575.
117. Shamblott M.J., Axelman J., Littlefield J.W., Blumenthal P.D., Huggins G.R., Cui Y., Cheng L., Gearhart J.D. Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:113-118.
118. Martin M.J., Muotri A., Gage F., Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 2005, 11:228-232.
119. Malykh Y.N., Schauer R., Shaw L. N-Glycolylneuraminic acid in human tumours. Biochimie 2001, 83:623-634.
120. Cerdan C., Bendall S.C., Wang L., Stewart M., Werbowetski T., Bhatia M. Complement targeting of nonhuman sialic acid does not mediate cell death of human embryonic stem cells. Nat. Med. 2006, 12:1113-1114.
121. Nasonkin I.O., Koliatsos V.E. Nonhuman sialic acid Neu5Gc is very low in human embryonic stem cell-derived neural precursors differentiated with B27/N2 and noggin: implications for transplantation. Exp. Neurol. 2006, 201:525-529.
122. Pan Y., Chefalo P., Nagy N., Harding C., Guo Z. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines. J. Med. Chem. 2005, 48:875-883.
123. Chefalo P., Pan Y.-B., Nagy N., Harding C., Guo Z.-W. Preparation and immunological studies of protein conjugates of N-acylneuraminic acids. Glycoconjug. J. 2004, 20:407-414.
124. Yarema K.J., Mahal L.K., Bruehl R.E., Rodriguez E.C., Bertozzi C.R. Metabolic delivery of ketone groups to sialic acid residues. Application to cell surface glycoform engineering. J. Biol. Chem. 1998, 273:31168-31179.
125. Mantey L.R., Keppler O.T., Pawlita M., Reutter W., Hinderlich S. Efficient biochemical engineering of cellular sialic acids using an unphysiological sialic acid precursor in cells lacking UDP-N-acetylglucosamine 2-epimerase. FEBS Lett. 2001, 503:80-84.
126. Gagiannis D., Gossrau R., Reutter W., Zimmermann-Kordmann M., Horstkorte R. Engineering the sialic acid in organs of mice using N-propanoylmannosamine. Biochim. Biophys. Acta. 2007, 1770:297-306.
127. Kim E.J., Sampathkumar S.-G., Jones M.B., Rhee J.K., Baskaran G., Yarema K.J. Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acetylmannosamine (ManNAc) analogs in Jurkat (human T-lymphoma-derived) cells. J. Biol. Chem. 2004, 279:18342-18352.
128. Springer W.R., Haywood P.L., Barondes S.H. Endogenous cell-surface lectin in Dictyostelium - quantitation, elution by sugar, and elicitation by divalent immunoglobulin. J. Cell Biol. 1980, 87:682-690.
129. Jones M.B., Teng H., Rhee J.K., Baskaran G., Lahar N., Yarema K.J. Characterization of the cellular uptake and metabolic conversion of acetylated N-acetylmannosamine (ManNAc) analogues to sialic acids. Biotechnol. Bioeng. 2004, 85:394-405.
130. Freitas R.A. Nanomedicine, Volume I: Basic Capabilities 1999, Landes Bioscience, Georgetown, TX.
131. Lavis L.D. Ester bonds in prodrugs. ACS Chem. Biol. 2008, 3:203-206.
132. Aich U., Campbell C.T., Elmouelhi N., Weier C.A., Sampathkumar S.-G., Choi S.S., Yarema K.J. Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxcity and MUC1 suppression. ACS Chem. Biol. 2008, 3:230-240.
133. Campbell C.T., Aich U., Weier C.A., Wang J.J., Choi S.S., Wen M.M., Maisel K., Sampathkumar S.-G., Yarema K.J. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogs inhibits the mobility of metastatic MDA-MB-231 breast cancer cell. J. Med. Chem. 2008, 51:8135-8147.
134. Elmouelhi N., Aich U., Paruchuri V.D.P., Meledeo M.A., Campbell C.T., Wang J.J., Srinivas R., Khanna H.S., Yarema K.J. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery. J. Med. Chem. 2009, 52:2515-2530.
135. Ding S., Schultz P.G. A role for chemistry in stem cell biology. Nat. Biotechnol. 2004, 22:833-840.
136. Ding S., Schultz P.G. Small molecules and future regenerative medicine. Curr. Top. Med. Chem. 2005, 5:383-395.
137. Meutermans W., Le G.T., Becker B. Carbohydrates as scaffolds in drug discovery. Chem. Med. Chem. 2006, 1:1164-1194.
138. Kageyama R., Ohtsuka T., Shimojo H., Imayoshi I. Dynamic Notch signaling in neural progenitor cells and a revised view of lateral inhibition. Nat. Neurosci. 2008, 11:1247-1251.
139. Hsu T.-L., Hanson S.R., Kishikawa K., Wang S.-K., Sawa M., Wong C.-H. Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2614-2619.
140. Tanaka Y., Kohler J.J. Photoactivatable crosslinking sugars for capturing glycoprotein interactions. J. Am. Chem. Soc. 2008, 130:3278-3279.